NYSE$HIMS

Hims & Hers Health Inc · Q3 2023 earnings

Q3 2023 earnings · · Investor relations

Briefing

Reported a strong third quarter with revenue growth and improved profitability.

Hims & Hers Health, Inc. reported a 57% year-over-year increase in revenue to $226.7 million for Q3 2023. The company achieved Adjusted EBITDA profitability of $12.3 million and grew its subscriber base to 1.4 million. They raised their full year 2023 revenue guidance to a range of $868 million to $873 million and Adjusted EBITDA guidance to a range of $43 million to $46 million.

  • Revenue increased by 57% year-over-year, reaching $226.7 million.
  • Net loss improved to $(7.6) million compared to $(18.8) million in the same quarter last year.
  • Adjusted EBITDA was $12.3 million, a significant improvement from $(6.1) million in the third quarter of 2022.
  • Subscribers grew to 1.4 million, representing a 56% increase year-over-year.

Headline financials

Total Revenue

$227M

Previous: $145M+56.5%
EPS (adj)

-$0.04

Previous: -$0.09+55.6%
Capital Expenditures

-$5.92M

No prior period
Free Cash Flow

-$7.57M

Previous: -$18.8M+59.8%
Net Income

-$7.57M

Previous: -$18.8M+59.8%
Operating Income

-$8.55M

Previous: -$20M+57.2%
Gross Profit

$187M

Previous: $114M+63.7%
Cash & Equivalents

$58M

Previous: $58M+0.1%
Total Assets

$414M

Previous: $383M+8.1%
Stock-Based Comp

$17.3M

Previous: $11M+57.4%

Revenue & EPS history

Hims & Hers · Revenue · Quarterly

$227M

Q3 2023+56.5%vs Q3 2022
Beat estimate in 10 of 15 quarters(67%)
ActualEstimate

Revenue by segment

Hims & Hers · $227M total across 2 segments · Q3 2023

  • Online Revenue
    $220M+57.1%
  • Wholesale Revenue
    $7.03M+39.1%

Forward guidance

For the fourth quarter 2023, the company expects revenue of $243 million to $248 million and Adjusted EBITDA of $14 million to $17 million. For the full year 2023, they expect revenue of $868 million to $873 million and Adjusted EBITDA of $43 million to $46 million.

Tailwinds

  • Revenue of $243 million to $248 million is expected for Q4 2023.
  • Adjusted EBITDA of $14 million to $17 million is expected for Q4 2023, reflecting an Adjusted EBITDA margin of 6% to 7%.
  • Revenue of $868 million to $873 million is expected for the full year 2023.
  • Adjusted EBITDA of $43 million to $46 million is expected for the full year 2023, reflecting an Adjusted EBITDA margin of approximately 5%.
  • Company anticipates continued growth and profitability.

Headwinds

  • Guidance constitutes forward-looking statements and actual results may differ materially.
  • The company cannot predict with reasonable certainty the ultimate outcome of certain components of such reconciliations.
  • Market-related assumptions are not within the company's control.
  • The company is unable to assess the probable significance of the unavailable information, which could materially impact the amount of future net loss.
  • Future results will be affected by expenses or any unusual or non-recurring items.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q3 2023

Historical avgQ3 2023

+2.5%

Avg return

Earnings day

+3.8%

Avg return

5 days after

+11.7%

Avg return

30 days after

50%

13 / 26 earnings

Positive

+41.1%

Q4 2023

Best reaction

-22.3%

Q4 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+3.0%-11.4%-1.8%
Q4 2025-2.8%-6.4%+34.5%
Q3 2025-3.6%-7.6%-9.8%
Q1 2025+18.5%+24.1%+26.0%
Q4 2024-22.3%-12.1%-37.8%
Q3 2024+1.4%+15.0%+66.6%
Q2 2024-4.0%-9.2%-16.9%
Q1 2024+9.7%+9.1%+93.2%
Q4 2023+41.1%+37.8%+65.3%
Q3 2023+7.6%+5.1%+37.3%
Q2 2023-8.7%-11.7%-15.2%
Q1 2023-11.5%-10.2%-23.9%
Q4 2022+15.4%+6.0%+2.7%
Q3 2022+30.1%+37.2%+64.7%
Q2 2022-3.4%+9.2%-0.6%
Q1 2022-13.0%-13.5%+5.3%
Q4 2021+8.0%+20.5%+19.8%
Q3 2021-7.0%-1.3%-26.3%
Q2 2021+7.0%-4.7%+11.1%
Q1 2021+13.7%+44.9%+33.1%
Q2 2020-8.4%-7.2%-21.9%
Q4 2020-7.5%-15.4%-21.3%
Q3 2020+0.1%+0.0%+17.5%
Q1 2020-0.7%-0.5%+0.1%
Q4 2019+1.4%+2.1%+2.2%
Q3 2019+0.0%+0.3%-0.6%
Q2 2019
Q1 2019

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro